Literature DB >> 11527794

Reciprocal interaction of human immunodeficiency virus and hepatitis C virus infections.

K E Nelson1, D L Thomas.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11527794      PMCID： PMC96162          DOI： 10.1128/CDLI.8.5.867-870.2001

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


× No keyword cloud information.
  52 in total

1.  Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease?

Authors:  M John; J Flexman; M A French
Journal:  AIDS       Date:  1998-12-03       Impact factor: 4.177

2.  Acute hepatitis in HIV-infected patients during ritonavir treatment.

Authors:  J R Arribas; C Ibáñez; B Ruiz-Antoran; J M Peña; C Esteban-Calvo; J Frías; J J Vázquez; J J González-García
Journal:  AIDS       Date:  1998-09-10       Impact factor: 4.177

3.  Hepatotoxicity after introduction of highly active antiretroviral therapy.

Authors:  R Rodríguez-Rosado; J García-Samaniego; V Soriano
Journal:  AIDS       Date:  1998-07-09       Impact factor: 4.177

4.  Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group.

Authors:  Y Benhamou; M Bochet; V Di Martino; F Charlotte; F Azria; A Coutellier; M Vidaud; F Bricaire; P Opolon; C Katlama; T Poynard
Journal:  Hepatology       Date:  1999-10       Impact factor: 17.425

5.  Hepatitis C in the HIV (human immunodeficiency virus) Atlanta V.A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): the effect of coinfection on survival.

Authors:  C T Staples; D Rimland; D Dudas
Journal:  Clin Infect Dis       Date:  1999-07       Impact factor: 9.079

6.  Hepatitis C virus is related to progressive liver disease in human immunodeficiency virus-positive hemophiliacs and should be treated as an opportunistic infection.

Authors:  O Lesens; M Deschênes; M Steben; G Bélanger; C M Tsoukas
Journal:  J Infect Dis       Date:  1999-05       Impact factor: 5.226

7.  Viral load and clinicopathological features of chronic hepatitis C (1b) in a homogeneous patient population.

Authors:  L Fanning; E Kenny; M Sheehan; B Cannon; M Whelton; J O'Connell; J K Collins; F Shanahan
Journal:  Hepatology       Date:  1999-03       Impact factor: 17.425

8.  Lack of evidence for the heterosexual transmission of hepatitis C.

Authors:  S C Gordon; A H Patel; G W Kulesza; R E Barnes; A L Silverman
Journal:  Am J Gastroenterol       Date:  1992-12       Impact factor: 10.864

9.  Lack of protective immunity against reinfection with hepatitis C virus.

Authors:  P Farci; H J Alter; S Govindarajan; D C Wong; R Engle; R R Lesniewski; I K Mushahwar; S M Desai; R H Miller; N Ogata
Journal:  Science       Date:  1992-10-02       Impact factor: 47.728

10.  Risk factors for hepatitis C virus seropositivity in heterosexual couples.

Authors:  D H Osmond; N S Padian; H W Sheppard; S Glass; S C Shiboski; A Reingold
Journal:  JAMA       Date:  1993-01-20       Impact factor: 56.272
View more
  2 in total

1.  Mother-to-Child Transmission of Hepatitis C Virus (HCV) Among HIV/HCV-Coinfected Women.

Authors:  Claudia A Checa Cabot; Sonia K Stoszek; Jorge Quarleri; Marcelo H Losso; Silvina Ivalo; Mario F Peixoto; José H Pilotto; Horacio Salomon; Leon C Sidi; Jennifer S Read
Journal:  J Pediatric Infect Dis Soc       Date:  2012-10-11       Impact factor: 3.164

Review 2.  Recent Advances in Plasma-Engineered Polymers for Biomarker-Based Viral Detection and Highly Multiplexed Analysis.

Authors:  Seyyed Mojtaba Mousavi; Seyyed Alireza Hashemi; Masoomeh Yari Kalashgrani; Ahmad Gholami; Navid Omidifar; Aziz Babapoor; Neralla Vijayakameswara Rao; Wei-Hung Chiang
Journal:  Biosensors (Basel)       Date:  2022-04-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.